Efficacy and safety of dovitinib in pretreated advanced squamous non-small cell lung cancer with FGFR1 amplification: A single-arm, phase II study

被引：2
|
作者：
Ahn, Myung-Ju [1 ]
Lim, Sung Hee [1 ]
Sun, Jong -Mu [1 ]
Choi, Yoon-La [1 ]
Kim, Hye Ryun [2 ]
Ahn, Soo-min [1 ]
Lee, Se-Hoon [1 ]
Ahn, Jin Seok [1 ]
Park, Keunchil [1 ]
Kim, Joo Hang [2 ]
Cho, Byoung Chul [2 ]
机构：
[1] Samsung Med Ctr, Seoul, South Korea
[2] Yunsei Univ, Seoul, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2016年 / 11卷 / 02期
关键词：
D O I：
10.1016/j.jtho.2015.12.027
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S16 / S16
页数：1
相关论文
共 50 条
  • [21] A single-arm phase II trial of pazopanib in patients with advanced non-small cell lung cancer with non-squamous histology with disease progression on bevacizumab containing therapy
    Weiss, Jared M.
    Villaruz, Liza C.
    Socinski, Mark A.
    Ivanova, Anastasia
    Grilley-Olson, Juneko
    Dhruva, Nirav
    Stinchcombe, Thomas E.
    LUNG CANCER, 2014, 86 (02) : 288 - 290
  • [22] Prospective, multicentre, single-arm phase II trial of pembrolizumab combined with carboplatin and pemetrexed in elderly patients with advanced, non-squamous non-small cell lung cancer
    Ozawa, Yuichi
    Sugimoto, Takeya
    Azuma, Yuichiro
    Harutani, Yuhei
    Yoshikawa, Takanori
    Yamamoto, Nobuyuki
    Kanai, Kuninobu
    BMJ OPEN, 2020, 10 (07):
  • [23] OVEREXPRESSION OF FGFR1 MRNA AND PROTEIN ARE MORE FREQUENT THAN FGFR1 GENE AMPLIFICATION IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS
    Wynes, Murry W.
    Boyle, Theresa
    Wojtylak, Szymon
    Sejda, Aleksandra
    Heasley, Lynn E.
    Henricksen, Leigh A.
    Singh, Shalini
    Camidge, David Ross
    Bunn, Paul A.
    Dziadziuszko, Rafal
    Biernat, Wojciech
    Hirsch, Fred R.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S280 - S280
  • [24] The Efficacy and Safety of Icotinib in Patients with Advanced Non-Small Cell Lung Cancer Previously Treated with Chemotherapy: A Single-Arm, Multi-Center, Prospective Study
    Hu, Xingsheng
    Zhang, Li
    Shi, Yuankai
    Zhou, Caicun
    Liu, Xiaoqing
    Wang, Dong
    Song, Yong
    Li, Qiang
    Feng, Jifeng
    Qin, Shukui
    Xv, Nong
    Zhou, Jianying
    Zhang, Li
    Hu, Chunhong
    Zhang, Shucai
    Luo, Rongcheng
    Wang, Jie
    Tan, Fenlai
    Wang, Yinxiang
    Ding, Lieming
    Sun, Yan
    PLOS ONE, 2015, 10 (11):
  • [25] Efficacy and Safety of Erlotinib Monotherapy for Japanese Patients with Advanced Non-small Cell Lung Cancer A Phase II Study
    Kubota, Kaoru
    Nishiwaki, Yutaka
    Tamura, Tomohide
    Nakagawa, Kazuhiko
    Matsui, Kaoru
    Watanabe, Koshiro
    Hida, Toyoaki
    Kawahara, Masaaki
    Katakami, Nobuyuki
    Takeda, Kohi
    Yokoyama, Akira
    Noda, Kazumasa
    Fukuoka, Masahiro
    Saijo, Nagahiro
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (12) : 1439 - 1445
  • [26] A phase II single-arm clinical trial involving and alternative cancer treatment psorinum therapy in patients with advanced non-small cell lung cancer
    Chatterjee, A.
    Biswas, J.
    Chatterjee, A. K.
    Bhattacharya, S.
    Mukhopadhyay, B. P.
    Chakraborty, A.
    Das, S.
    Bhakta, R. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [27] Phase II study of plitidepsin in pretreated patients with localty advanced or metastatic non-small cell lung cancer
    Peschel, Christian
    Hartmann, Joerg T.
    Schmittet, Alexander
    Bokemeyer, Carsten
    Schneller, Folker
    Keilholz, Ulrich
    Buchheidt, Dieter
    Millan, Susana
    Izquierdo, Miguel Angel
    Hofheinz, Ralf-Dieter
    LUNG CANCER, 2008, 60 (03) : 374 - 380
  • [28] Evaluation of pembrolizumab for the treatment of advanced non-small cell lung cancer: a retrospective, single-centre, single-arm study
    Guo, Tianxing
    Ding, Yun
    Chen, Long
    Zhu, Lihuan
    Lin, Jinlan
    Zhang, Jiguang
    Huang, Yangyun
    Li, Wujin
    Lin, Rongjia
    Pan, Xiaojie
    JOURNAL OF THORACIC DISEASE, 2021, 13 (01) : 282 - 290
  • [29] Efficacy and safety of iruplinalkib (WX-0593) in ALK-positive crizotinib-resistant advanced non-small cell lung cancer patients: a single-arm, multicenter phase II study (INTELLECT)
    Yuankai Shi
    Jianhua Chen
    Helong Zhang
    Zhihong Zhang
    Yiping Zhang
    Zhehai Wang
    Shucai Zhang
    Jian Zhao
    Chunling Liu
    Xiuwen Wang
    Yanqiu Zhao
    Changlu Hu
    Lei Yang
    Xuezhi Hao
    Lin Wang
    Yunpeng Liu
    Yan Yu
    Jun Zhao
    Mengzhao Wang
    Liangming Zhang
    Sanyuan Sun
    Yanping Hu
    Kangsheng Gu
    Xiaosheng Hang
    Jinlu Shan
    Yu Zhang
    Bangxian Tan
    Weihua Yang
    Runxiang Yang
    Meimei Si
    Huaize Geng
    Hui Li
    Xiaoyan Kang
    BMC Medicine, 21
  • [30] Efficacy and safety of iruplinalkib (WX-0593) in ALK-positive crizotinib-resistant advanced non-small cell lung cancer patients: a single-arm, multicenter phase II study (INTELLECT)
    Shi, Yuankai
    Chen, Jianhua
    Zhang, Helong
    Zhang, Zhihong
    Zhang, Yiping
    Wang, Zhehai
    Zhang, Shucai
    Zhao, Jian
    Liu, Chunling
    Wang, Xiuwen
    Zhao, Yanqiu
    Hu, Changlu
    Yang, Lei
    Hao, Xuezhi
    Wang, Lin
    Liu, Yunpeng
    Yu, Yan
    Zhao, Jun
    Wang, Mengzhao
    Zhang, Liangming
    Sun, Sanyuan
    Hu, Yanping
    Gu, Kangsheng
    Hang, Xiaosheng
    Shan, Jinlu
    Zhang, Yu
    Tan, Bangxian
    Yang, Weihua
    Yang, Runxiang
    Si, Meimei
    Geng, Huaize
    Li, Hui
    Kang, Xiaoyan
    BMC MEDICINE, 2023, 21 (01)
12345